 Hoth Therapeutics, Inc. NASDAQ: HOTH, a biopharmaceutical company, today announced that the United States Patent and Trademark Office USPTO has issued a Notice of Allowance for US Patent Application Number: 15528,317 related to 13-Cis-RAMBA Retinamides that Degrade MNKs for Treating Cancer. 